MRE11 meiotic recombination 11 |
MRE11
|
5′-CTCAGCAGCAACCAACAAAG-3′ |
5′GTGTCTCTTCCTCTTTGAGACC-3′ |
RAD50 homolog |
RAD50
|
5′-GAATCTAGGCTTCTCAATCAGG-3′ |
5′-CTCTAGCTCGGATATGTTCTTG-3′ |
Nibrin |
NBS1
|
5′-CCACCTCCAAAGACAACTG-3′ |
5′-AGGACGGCAGGAAAGAA-3′ |
CHECK1 checkpoint homolog |
CHECK1
|
5′-TCTGTTGGATGAAAGGGATAAC-3′ |
5′-TCAACAAACGCTCACGATTA-3′ |
CHECK2 checkpoint homolog |
CHECK2
|
5′-GTGTCCACTCAGGAACTCTATTC-3′ |
5′CATCCTGAAGGGCCCATAATC-3′ |
Breast cancer 1, early onset |
BRCA1
|
5′-CAAGAAGAGCAAAGCATGGA-3′ |
5′-GAGGATAGCCCTGAGCAGTC-3′ |
Breast cancer 2, early onset |
BRCA2
|
5′-TTTGCGTTGAGGAACTTGTG-3′ |
5′-AGGTGGCCCTACCTCAAAAT-3′ |
RAD51 homolog |
RAD51
|
5′-AAAGGAAGAGGGGAAACCAG-3′ |
5′-ATCTCCCACTCCATCTGCAT-3′ |
RAD17 homolog |
RAD17
|
5′-GTGGTTTAAGGAGCGGTCAG-3′ |
5′-TTTGCATCCTGAATTAGTCCTTC-3′ |
MutS homolog 2 |
MSH2
|
5′-AAGAAGTGCTATCTGGAAAGAG-3′ |
5′-ACATTTCAGTAAAGGGCATTTG-3′ |
Exonuclease 1 |
EXO1
|
5′-AGGGAAAGCAACTTCTTCG-3′ |
5′-GCCATGGCATGTGTGATA-3′ |
Vitamin D receptor |
VDR
|
5′- ATGCCATCTGCATCGTCTC-3′ |
5′-GCACCGCACAGGCTGTCCTA-3′ |
18 S Ribosomal RNA |
18 S rRNA
|
5′-CGAACGTCTGCCCTATCAACTT-3′ |
5′-ACCCGTGGTCACCATGGTA-3′ |